Cefixime
10 NDCs across 3 manufacturers|10 Generic,0 Brand
Cefixime is used to treat bronchitis, escherichia coli infections, gonorrhea, haemophilus infections, klebsiella infections and moraxellaceae infections, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Apr 28, 1989, and the first generic was approved Feb 12, 2004. FDA's Orange Book lists 14 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $2 million on Cefixime across 18,000 claims for 14,000 beneficiaries.
Cefixime is available as 10 NDCs from 3 manufacturers (10 generic, 0 brand), with NADAC prices from $2.44 to $5.69 per ML — the most expensive product costs about 2.3× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
10
10G / 0B
Manufacturers
3
competing in market
Price Spread
$2.44 – $5.69
per ML, 6 of 10 NDCs
7d Activity
avg -1.2% WoW · of 10 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Lupin Pharmaceuticals Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Cephalosporin Antibacterial class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
3 manufacturers producing CEFIXIME
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
CEFIXIME 400 MG CAPSULE | $10.0282 per EA | +1.12% |
CEFIXIME 400 MG CAPSULE | $10.0282 per EA | +1.12% |
CEFIXIME 400 MG CAPSULE | $10.0282 per EA | +1.12% |
CEFIXIME 400 MG CAPSULE | $10.0282 per EA | +1.12% |
CEFIXIME 200 MG/5 ML SUSP | $5.6934 per ML | — |
CEFIXIME 200 MG/5 ML SUSP | $5.6934 per ML | — |
CEFIXIME 200 MG/5 ML SUSP | $3.4266 per ML | -6.98% |
CEFIXIME 200 MG/5 ML SUSP | $3.4266 per ML | -6.98% |
CEFIXIME 100 MG/5 ML SUSP | $2.8771 per ML | — |
CEFIXIME 100 MG/5 ML SUSP | $2.4430 per ML | +0.87% |
Frequently Asked Questions
What is Cefixime used to treat?
Cefixime is used to treat bronchitis, escherichia coli infections, gonorrhea, haemophilus infections, klebsiella infections and moraxellaceae infections, per the National Library of Medicine's MED-RT classification.
When did Cefixime become available as a generic?
FDA approved the first generic Cefixime (ANDA) on Feb 12, 2004. The Orange Book currently lists 14 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Cefixime?
In 2024, Medicare Part D spent $2 million on Cefixime across 18,000 claims for 14,000 beneficiaries.
How many Cefixime products are on the market?
The Cefixime drug market contains 10 NDCs from 3 manufacturers — 10 generic and 0 brand products.
What is the price range for Cefixime?
NADAC reference prices for Cefixime range from $2.4430 to $5.6934 per ML — the most expensive product costs about 2.3× the cheapest. 4 additional products are priced per different units (e.g. liquids per ML) and aren't directly comparable.
Which manufacturers make Cefixime?
3 manufacturers list Cefixime in NADAC. Ranked by number of NDCs, the largest are Lupin Pharmaceuticals Inc. (5), Aurobindo Pharma Limited (3), Ascend Laboratories, LLC (2).
How has the price of Cefixime changed recently?
Over the past 7 days, 5 Cefixime NDCs rose and 2 fell, with a market-wide average change of -1.2%.